In the final week of the Musk v. Altman trial, lawyers traded blows over Elon Musk’s and OpenAI CEO Sam Altman’s credibility. Altman was grilled on his alleged history of lying and self-dealing involving companies that do business with OpenAI. But he fired back, painting Musk as a power-seeker who wanted to control the development…
OpenAI is refocusing its research efforts and throwing its resources into a new grand challenge. The San Francisco firm has set its sights on building what it calls an AI researcher, a fully automated agent-based system that will be able to go off and tackle large, complex problems by itself. OpenAI says that the new…
This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over…
This article outlines how leaders can identify high-potential talent within the first 30 days by observing the subtle behaviors that signal accelerated growth potential.
Regulatory change is inevitable, but how leaders operationalize it often determines whether their organization stays in control — or falls into reactive chaos.
As an entrepreneur, you can’t afford vague messaging. When your value proposition is unclear, every sales conversation becomes harder than it needs to be.